5 Oversold Biotech Stocks To Buy Right Now

Page 5 of 5

1. AN2 Therapeutics Inc. (NASDAQ:ANTX)

Number of Hedge Fund Holders: 17

14-day RSI Value: 17.4

A Market Perform rating and $7 price target were maintained on AN2 Therapeutics Inc. (NASDAQ:ANTX) on February 13 by Joseph Schwartz at Leerink Partners.

There were 17 hedge funds long AN2 Therapeutics Inc. (NASDAQ:ANTX) in the fourth quarter, with a total stake value of $252.1 million.

AN2 Therapeutics Inc. (NASDAQ:ANTX) is a clinical-stage biotech company that develops treatments for rare, chronic, and serious infectious diseases. It is based in Menlo Park, California.

Follow An2 Therapeutics Inc. (NASDAQ:ANTX)

See also 12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds and 10 Biotech Stocks with Huge Potential.

Page 5 of 5